Orion Corporation (“Orion”) and Newel Health (“Newel”) have entered into a license agreement regarding ODD-403 (“Rohkea”), a digital therapeutic (DTx)…
-Deliberate AI, a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.
ATHERTON, Calif.--(BUSINESS WIRE)--WellTheory, a first-of-its-kind virtual solution for the 50 million Americans suffering with autoimmune disease, to…
Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, announced that it has received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD) from its Notified Body, the BSI Group.
wift Medical, a digital health technology company serving wound care providers, is pleased to announce the successful closing of an $US8M round of financing co-led by current investors BDC Capital’s Women in Technology Venture Fund and funds managed by Virgo Investment Group.
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, have reached an agreement to define and discover biomarkers within the DNA Damage Repair (DDR) biology space to predict the clinical benefit of one or more drugs in Debiopharm’s pipeline.
Boston Imaging, the United States headquarters of Samsung’s digital radiography (DR) and ultrasound business, today announced that Samsung has signed a supply contract with Lunit Inc., a leading provider of artificial intelligence (AI) powered solutions for cancer diagnostics and therapeutics, to enable faster and more accurate chest screenings for timely interventions with improved patient outcomes.
Isaac Health, a digital health company emerging as a national leader for brain health, announced today the successful completion of its oversubscribed $5.7 million Seed round. The round was led by Meridian Street Capital and B Capital with participation from Primetime Partners, Co-Found Partners, VU Venture Partners, and AirAngels.
Cross-Border Impact Ventures (CBIV) today announced the final closing of its first fund after exceeding US$90 million in investor commitments. The Women’s and Children’s Health Technology Fund is focused on investments in technology companies that address the health needs of women, children, and adolescents or make health systems more resilient.
SAN FRANCISCO--(BUSINESS WIRE) Demy-Colton and EBD Group’s Biotech Showcase™, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees – including a record-breaking 1,285 investors and 110 members of the media